GW1929

UP427415723196808-24-9

Clofibrate

UP863757481637-07-0

Balaglitazone

UP328572285199113-98-9

(S)-2-(Benzylamino)-2-(4-fluorophenyl)acetic acid

UP371448646159707-18-3

ONO-4059 hydrochloride

UP2052931031439901-97-9

Omadacycline

UP764305268389139-89-3

CYP11B1 Inhibitor C25

UP5020167502101952-78-5

Debio 0617B

UP8193692191332329-27-7

BMS-687453

UP9040206751000998-59-3

Pemafibrate racemate

UP618456855848258-31-1

Acalabrutinib

UP3333335651420477-60-6

NVP-AEW541

UP592173570475489-16-8

Cerdulatinib Hydrochloride

UP9968674041369761-01-2

KU14R

UP984114432189224-48-4

AZD5438

UP720888896602306-29-6

AT7519

UP462295079844442-38-2

NVP-BSK805

UP7001806891092499-93-8

Tofacitinib

UP532567784477600-75-2

Hoechst 33258 analog

UP739536229258843-62-8

GSK3787

UP400040471188591-46-0

Seratrodast

UP399854375112665-43-7

LY2784544

UP8632234231229236-86-5

XL413

UP8181673771169558-38-6

WHI-P154

UP458340517211555-04-3

(S)-2-((S)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-3-phenylpropanamido)-3-phenylpropanoic acid

UP68976991184889-09-8

GDC-0834 Racemate

UP4336970211133432-46-8

Arjunolic acid

UP532003457465-00-9

TMS

UP16586340024144-92-1

PH-797804

UP828345760586379-66-0

Tofacitinib citrate

UP572148884540737-29-9

Pemafibrate

UP750775875848259-27-8

ONO-1301

UP295338461176391-41-6

NT157

UP6109634301384426-12-3